ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00255138
Recruitment Status : Withdrawn
First Posted : November 17, 2005
Last Update Posted : October 31, 2008
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by:
Temple University

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given